Fulyzaq is designed to treat diarrhea in patients taking HIV and AIDS drugs.
Stories Related to Company: Fda Approved Diarrhea Drug
USATODAY.com Feed, USA Today
Wed, 01/02/2013 - 4:51am
RELATED ARTICLES
- Cancer Physicians Attack High Drug Costs
More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More - Swedish police find drugs on Bieber tour bus
The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More - AIDS Vaccine Path Suggested by Study
By tracking one patient’s immune response, scientists have tracked how a series of mutations led to an antibody that can defeat many H.I.V. strains. More - New FDA research finds 12% of retail chicken has salmonella, 74% of which is antibiotic-resistant
Perhaps, like me, you’ve wondered what percentage of retail meat has foodborne pathogens, and of those, which pathogens are antibiotic resistant. Well, you’re in luck. The Food and Drug Administration’s National Antimicrobial Resistance Monitoring System puts out a yearly report looking at the rates of antibiotic resistance of foodborne pathogens in retail meat and poultry samples. More - HIV Test Urged for 7,000 Oklahoma Dental Patients
Health officials are urging 7,000 patients of an Oklahoma dentist to seek medical tests to ensure they haven't been exposed to hepatitis or the virus that causes AIDS. The Oklahoma and Tulsa health departments say the patients may have been exposed to viruses at clinics operated by W. More
BING NEWS:
- Bausch wins US appeal to block Alvogen generic of diarrhea drug
A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival drugmaker Alvogen from marketing a proposed generic version of Bausch's diarrhea treatment Xifaxan until 2029.
04/11/2024 - 5:05 am | View Link - ‘How I Learned To Talk About My Major Depressive Disorder in the Hispanic Community’
"My depression started to take more of a toll on me," she says. "I had feelings of worthlessness, lost a lot of weight, and I was tired all of the time. I lost interest in things I once enjoyed like ...
04/9/2024 - 3:07 am | View Link - AACR 2024: What Cancer Researchers Are Talking About
With the American Association for Cancer Research’s annual conference well underway, data from vaccines and other products targeting tough-to-treat cancers have dominated the program.
04/5/2024 - 8:48 am | View Link - FDA Approves Basilea’s ZEVTERA® for Severe Bacterial Infections, Including Pediatric Use
Basilea Pharmaceutica Ltd, a biopharmaceutical company, has received approval from the US Food and Drug Administration (FDA) for ZEVTERA® (cefto ...
04/4/2024 - 12:34 am | View Link - After 'The Ozempic Panic,' Controversial Weight-loss Drug Wegovy Approved for Use in Israel
Three years after its FDA approval, Wegovy is now available to buy on prescription in Israel, with prices starting at 600 shekels ($163) per month. Some doctors expect high demand among non-obese ...
04/2/2024 - 3:56 am | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more